Mark Roseman

photo of Mark Roseman(MPH, DSc, Boston University)

Mark Roseman is the Senior Vice President of Aruvant Sciences, a biotechnology company in Cincinnati, Ohio working to develop a gene therapy product for the treatment of sickle cell disease. Mark has spent over 25 years in the clinical trials industry, primarily working for Clinical Research Organizations such as PPD and Medpace. After graduating from Miami University with a degree in engineering physics, Mark earned his Master of Public Health (MPH) and Doctor of Science (DSc) degrees from Boston University.